| Dr Alyssa Michelle Feiner, MD | |
|
142 Collins St, Memphis, TN 38112-3810 | |
| (866) 957-0425 | |
| Not Available |
| Full Name | Dr Alyssa Michelle Feiner |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 20 Years |
| Location | 142 Collins St, Memphis, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326246737 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0900X | Dermatology - Dermatopathology | 46681 (Tennessee) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Shore Medical Group Of The Mount Sinai School Of Medicine | 8921999087 | 270 |
News Archive
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The patent relates to human microRNA miR-193b, as well as to complementary probes and vectors. This is the third patent issued to Rosetta Genomics by the USPTO.
Patients hospitalised with bipolar disorder are at the greatest risk of suicide immediately after discharge, and the rate at which the risk declines depends on the illness phase, Finnish researchers report.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have shed new light on Ewing's sarcoma, an often deadly bone cancer that typically afflicts children and young adults. Their research shows that patients with poor outcomes have tumors with high levels of a protein known as GSTM4, which may suppress the effects of chemotherapy. The research is published online today in the journal Oncogene.
Lockheed Martin has won a $47.8 million contract to develop and integrate software applications for the Department of Defense's Theater Medical Information Program (TMIP), Block 2.
› Verified 5 days ago
| Entity Name | North Shore Medical Group Of The Mount Sinai School Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275640609 PECOS PAC ID: 8921999087 Enrollment ID: O20040320000412 |
News Archive
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The patent relates to human microRNA miR-193b, as well as to complementary probes and vectors. This is the third patent issued to Rosetta Genomics by the USPTO.
Patients hospitalised with bipolar disorder are at the greatest risk of suicide immediately after discharge, and the rate at which the risk declines depends on the illness phase, Finnish researchers report.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have shed new light on Ewing's sarcoma, an often deadly bone cancer that typically afflicts children and young adults. Their research shows that patients with poor outcomes have tumors with high levels of a protein known as GSTM4, which may suppress the effects of chemotherapy. The research is published online today in the journal Oncogene.
Lockheed Martin has won a $47.8 million contract to develop and integrate software applications for the Department of Defense's Theater Medical Information Program (TMIP), Block 2.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alyssa Michelle Feiner, MD 5680 Shady Grove Rd, Memphis, TN 38120-2424 Ph: (901) 761-7801 | Dr Alyssa Michelle Feiner, MD 142 Collins St, Memphis, TN 38112-3810 Ph: (866) 957-0425 |
News Archive
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The patent relates to human microRNA miR-193b, as well as to complementary probes and vectors. This is the third patent issued to Rosetta Genomics by the USPTO.
Patients hospitalised with bipolar disorder are at the greatest risk of suicide immediately after discharge, and the rate at which the risk declines depends on the illness phase, Finnish researchers report.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have shed new light on Ewing's sarcoma, an often deadly bone cancer that typically afflicts children and young adults. Their research shows that patients with poor outcomes have tumors with high levels of a protein known as GSTM4, which may suppress the effects of chemotherapy. The research is published online today in the journal Oncogene.
Lockheed Martin has won a $47.8 million contract to develop and integrate software applications for the Department of Defense's Theater Medical Information Program (TMIP), Block 2.
› Verified 5 days ago
Dr. Emily T. Overholser, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1455 Union Ave, Memphis, TN 38104 Phone: 901-726-6655 Fax: 901-726-9056 | |
Dr. Maureen Poh, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1910 Nonconnah Blvd, Suite 120, Memphis, TN 38132 Phone: 901-448-2300 Fax: 901-448-6657 | |
Dr. Robert B Skinner, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1910 Nonconnah Blvd, Suite 120, Memphis, TN 38132 Phone: 901-448-2300 Fax: 901-448-6657 | |
Dr. Mark Harris Tanenbaum, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 760 Brookhaven Circle, Memphis, TN 38117 Phone: 901-761-0500 Fax: 901-761-0537 | |
Dr. Alan Harris Tanenbaum, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 760 E Brookhaven Cir, Memphis, TN 38117 Phone: 901-761-0500 | |
Dr. Courtney Stroupe Woodmansee, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1455 Union Ave, Memphis, TN 38104 Phone: 901-726-6655 | |
Dr. Srinidhi Reddy Pulusani, MD Dermatology Medicare: Medicare Enrolled Practice Location: 930 Madison Ave Ste 801, Memphis, TN 38103 Phone: 901-866-8805 Fax: 901-302-2790 |